IDP Pharma is at the forefront of drug discovery, utilizing its proprietary INTRAMETICS™ platform to develop innovative therapies targeting intrinsically disordered proteins (IDPs). This platform represents a significant advancement in the pharmaceutical industry, as it enables the design of drugs that can effectively engage with IDPs, which have historically posed challenges for therapeutic modulation. The company's approach focuses on activating the degradation of these proteins through the intrinsic cellular machinery, offering potential breakthrough treatments for various incurable diseases and cancers. Recent developments include the initiation of clinical trials for IDP-121, a direct cMyc protein inhibitor, and IDP-410, a direct N-MYC protein inhibitor, showcasing the platform's versatility and efficacy in addressing complex medical needs.

In addition to its core focus on oncology, IDP Pharma is expanding its therapeutic reach through strategic partnerships, such as the licensing option for IDP-602, which targets IDPs associated with eye diseases. This collaboration highlights the adaptability of the INTRAMETICS™ platform, allowing for the exploration of applications beyond cancer treatment. The company's commitment to addressing unmet medical needs is further underscored by its ongoing clinical trials and the development of novel drug candidates, positioning IDP Pharma as a leader in the quest for effective therapies against challenging disease drivers.

Spain

IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). We are currently focused on exploiting new mechanisms of action to treat cancer diseases.

Our efforts are directed towards promoting a real shift in cancer therapies to improve the lives of patients. To this end, we have built an extraordinary committed team of experts in the field, supported by a professional advisory board, including IDPs and diseases experts, and business professionals.

IDP-Pharma

Company Details